Clinical Trials Logo
  1. Home
  2. Deep Vein Thrombosis (DVT)
  3. NCT02205294

Osteopathic Treatment and Deep Vein Thrombosis (DVT)

Deep Vein Thrombosis (DVT) Clinical Trial

Official title:
The Effect of Osteopathic Treatment in Acute Proximal Leg Deep Vein Thrombosis (DVT) to Reduce Pain and Swelling

Clinical Trial Summary

Osteopathic treatment will provide: 1. A significant reduction of pain and swelling of the affected DVT leg 2. An increase in the quality of life (QOL) for individuals with DVT of the leg 3. Improved signs and symptoms of the post thrombotic syndrome of the affected DVT leg

Clinical Trial Description

Thousands of individuals are affected by deep vein thrombosis (DVT) every year. Medical treatment is aimed at preventing extension and recurrence of the blood clot (DVT) through the use of anticoagulation medication. Compression stockings may be added for reduction of pain and swelling, but this therapy remains controversial amongst physicians. To date, there is limited manual therapies available for individuals affected with DVT. Regular medical treatment, anticoagulation medication, along with osteopathic treatment may offer these individuals improved control of the symptoms associated with DVT. In the long term osteopathic treatment may provide an increase in the quality of life (QOL) and improve the signs and symptoms associated with the post-thrombotic syndrome (PTS), which can be burdensome for both the individual and the health care system. Offering an effective add on treatment could provide individuals and the medical system with an additional means of treatment for the symptoms of DVT and also for the prevention of development of PTS. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02205294
Study type Interventional
Source Nova Scotia Health Authority
Contact
Status Completed
Phase N/A
Start date November 6, 2014
Completion date April 4, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT02523937 - Evaluation of Soluble Fibrin in Thrombosis Exclusion
Terminated NCT03805672 - Below Knee DVT Study Phase 4
Completed NCT00986154 - Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). Phase 3
Completed NCT02798471 - Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) Phase 3
Completed NCT02210819 - Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
Completed NCT01630148 - Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries N/A
Completed NCT02073682 - Cancer Venous Thromboembolism (VTE) Phase 3
Recruiting NCT06195787 - Improving Emergency Department Testing for Deep Vein Thrombosis
Recruiting NCT02342444 - Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) Phase 4
Completed NCT02744092 - Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer N/A
Recruiting NCT02156401 - VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE